Lilly’s antibody IV infusions for coronavirus patients to present ‘unique challenges,’ top officials say
November 11 2020, 08:00
While Eli Lilly’s investigational antibody drug, bamlanivimab, just received FDA emergency approval to treat mild coronavirus patients, top officials voiced concerns over its challenging IV infusion process.
While Eli Lilly’s investigational antibody drug, bamlanivimab, just received FDA emergency approval to treat mild coronavirus patients, top officials voiced concerns over its challenging IV infusion process.
Source:
FOX News